Orexigen Therapeutics (OREX) is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. This stock is trading up 7.6% to $4.95 in recent trading.
Today's Range: $4.65-$5.1452-Week Range: $1.26-$7.73 Volume: 2.9 million Three-Month Average Volume: 4.1 million Shares of OREX are ripping higher today in front of its presentation at an investor conference on Wednesday, and after it released related information about its ongoing drug studies ahead of the meeting. >>5 Rocket Stocks Worth Buying This Week From a technical perspective, OREX is bouncing sharply here right off some near-term support at $4.50 with decent volume. This move is quickly pushing OREX within range of triggering a major breakout trade. That trade will hit once OREX clears some near-term overhead resistance at $4.85, and then once it takes out its 50-day moving average of $5.11 with high volume. At last check, OREX has hit an intraday high of $5.14 and volume is about 1 million shares below its three-month average action of 4,075,770 shares. Traders should now look for long-biased trades in OREX once it sustains a move or close above $4.85 to $5.11 with volume that's near or above 4.1 million shares. If that breakout triggers soon, then OREX has a great chance of heading north of $6, and possibly tagging its July high of $7.73. Traders should key off of $4.50 to $4.30 as support zones if you buy off weakness.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV